Pharma Core
Pharma Core, headquartered in Switzerland (CH), is a prominent player in the pharmaceutical industry, specialising in innovative drug development and manufacturing solutions. Established in 2005, the company has made significant strides in enhancing healthcare through its advanced biopharmaceutical products and services, catering to both local and international markets. With a focus on precision medicine and biologics, Pharma Core stands out for its commitment to quality and regulatory compliance, ensuring that its offerings meet the highest industry standards. The company has achieved notable milestones, including successful collaborations with leading healthcare organisations, which have solidified its position as a trusted partner in the pharmaceutical landscape. Through its dedication to research and development, Pharma Core continues to drive advancements that improve patient outcomes and contribute to the evolving needs of the healthcare sector.
DitchCarbon Score
How does Pharma Core's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Core's score of 26 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Core's reported carbon emissions
Pharma Core, headquartered in Switzerland (CH), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is essential to highlight that Pharma Core is committed to addressing climate change through various initiatives. However, specific reduction targets or climate pledges have not been disclosed. As the pharmaceutical industry increasingly prioritises sustainability, Pharma Core's future commitments and strategies will be crucial in aligning with global climate goals and reducing its environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Core is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
